Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 18.10
+0.10 (0.56%)
Apr 17, 2026, 1:30 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.95 billion as of April 17, 2026. Its market cap has decreased by -10.74% in one year.
Market Cap
2.95B
Enterprise Value
3.92B
Revenue
107.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.10
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.95B, a decrease of -26.36%. That is a compound annual growth rate of -2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.95B | 1.69% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shine-On BioMedical | 3.29B |
| SYN-TECH Chem. & Pharm. | 3.22B |
| BRIM Biotechnology | 3.19B |
| Apex Biotechnology | 2.96B |
| Syngen Biotech | 2.87B |
| HeXun Biosciences | 2.80B |
| TWi Biotechnology | 2.70B |
| Sinew Pharma | 2.67B |